September 24, 2021
As a leader in neuroscience, Biogen seeks to engage with those who are championing revolutionary ideas in multiple areas of neuroscience as well as next generation of drug discovery technologies and platforms.
External Innovation Unit
The External Innovation Unit represents Biogen by establishing a global network with industry, academia and others to foster external collaborations, driving innovation while strengthening the neuroscience ecosystem.
LabCentral is a first-of-its-kind, shared laboratory space designed to launch life science and biotech start-ups. LabCentral provides the infrastructure entrepreneurs and innovators need to test out, challenge and nurture their ideas.
As a platinum sponsor, Biogen’s External Innovation Unit can nominate up to two early-stage companies each year to take up residence in LabCentral's Kendall Square facilities. Each Biogen-LabCentral Golden Ticket includes up to one year of bench space for one scientist and the benefits of LabCentral's shared infrastructure and services at no cost to the contest winner. See https://labcentral.org/facilities-services.
Special consideration will be provided to proposals focused on neuroscience, neurodegeneration and areas related to Biogen research.
Competition Rules, Eligibility and Judging Criteria
Applicants who meet the eligibility criteria for the Biogen-LabCentral Golden Ticket Competition can follow the link below to submit an application, including a brief non-confidential proposal, by 11:59 p.m., ET, on September 24. More information can be found under Eligibility criteria, terms and conditions.
Submit your application here, and read the eligibility criteria, terms, and conditions.
Last year's winners of Biogen Golden Tickets were: Bolden Therapeutics and Seranova Bio.